Our proprietary metadata reveals how alt data is developing in new markets around the world, highlighting not only the most popular datasets in each region but also looking at trends in pricing and adoption.

We revisit the ever-changing world of consumer transaction data, exploring developments in e-receipts, point-of-sale and credit and debit card data.

While Ozempic stole 2023’s healthcare headlines, the sector also saw an uptick in private equity interest. In this intelligence piece we explore key areas where alternative data can offer additional insights.

We look back at last year’s contribution to the alternative data landscape. New jargon has made its way into common use, while leading alt data categories have seen their ecosystems disrupted. Below, we look at what these developments mean for data buyers and sellers, and how the landscape is changing.